Russian firm seeks to produce COVID-19 drug remdesivir without patent
Russian drugmaker Pharmasyntez has asked the Kremlin to allow it to produce a generic version of US
Russian drugmaker Pharmasyntez has asked the Kremlin to allow it to produce a generic version of US